<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: The purpose of this study is to investigate whether <z:chebi fb="0" ids="2781">apocynin</z:chebi>, an <z:chebi fb="0" ids="50423">NADPH oxidase inhibitor</z:chebi>, attenuates vasospasm after experimental <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> (SAH) in rats </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Rats were subjected to endovascular <z:mpath ids='MPATH_81'>perforation</z:mpath> of the right anterior cerebral artery or sham surgery </plain></SENT>
<SENT sid="2" pm="."><plain>Beginning 2 hours after SAH, rats were administered 50 mg/kg <z:chebi fb="0" ids="2781">apocynin</z:chebi> or vehicle by intraperitoneal injection 3 times daily for 2 days </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: In SAH rats, <z:chebi fb="0" ids="2781">apocynin</z:chebi> treatment enlarged basilar artery diameter (SAH/<z:chebi fb="0" ids="2781">apocynin</z:chebi>=253+/-71 microm, SAH/saline=191+/-60 microm, P&lt;0.01; SAH=190+/-58 microm, sham=276+/-52 microm, P&lt;0.01), reduced neurological deficits (SAH/<z:chebi fb="0" ids="2781">apocynin</z:chebi>=24+/-6.5, SAH/saline=18+/-5.3, P&lt;0.05; SAH=18+/-4.7, sham=27+/-0, P&lt;0.01), decreased <z:chebi fb="1" ids="16474">NADPH</z:chebi> oxidase activity (SAH/<z:chebi fb="0" ids="2781">apocynin</z:chebi>=18.4+/-3.7, SAH/saline=25.7+/-5.2, P&lt;0.05; SAH=27.5+/-5.8, sham=15.4+/-4.5 nmol/min per mg protein, P&lt;0.05), decreased <z:chebi fb="1" ids="18421">superoxide</z:chebi> level (SAH/<z:chebi fb="0" ids="2781">apocynin</z:chebi>=6.5+/-1.8, SAH/saline=9.6+/-2.2, P&lt;0.05; SAH=9.8+/-1.9, sham=4.9+/-0.9 arbitrary units, P&lt;0.05), and lowered membrane translocation of <z:chebi fb="1" ids="16474">NADPH</z:chebi> oxidase subunit p47phox </plain></SENT>
<SENT sid="4" pm="."><plain>CONCLUSIONS: Inhibition of <z:chebi fb="1" ids="16474">NADPH</z:chebi> oxidase attenuates delayed <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> after experimental SAH, suggesting that the inhibition of <z:chebi fb="1" ids="16474">NADPH</z:chebi> oxidase may provide a therapeutic strategy for vasospasm after SAH </plain></SENT>
</text></document>